SCHEMBL16449330

SCHEMBL16449330

Cc1cc(C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)C3(C)CC3)NC(=O)[C@@H]3C[C@@H](Oc4nc5cc(OC(F)(F)F)ccc5c5ccc(F)cc45)CN3C2=O)no1

nearest known ligand 0.45

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.45
▸ ADRB3 P13945 1/20 0.38
▸ ADRA2B P18089 1/20 0.38
▸ ADRA2C P18825 1/20 0.38
▸ CTSB P07858 1/20 0.37
▸ CTSS P25774 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13976020 0.98 CYP3A4 (0.45) CYP3A4ADRB3ADRA2BADRA2CCTSB
SCHEMBL13975941 0.98 CYP3A4 (0.45) CYP3A4ADRB3ADRA2BADRA2CCTSB
SCHEMBL13975131 0.94 CYP3A4 (0.44) CYP3A4ADRB3ADRA2BADRA2CCTSB
SCHEMBL16449339 0.94 CYP3A4 (0.46) CYP3A4ADRB3ADRA2BADRA2CCTSB
SCHEMBL16449351 0.93 CYP3A4 (0.46) CYP3A4ADRB3ADRA2BADRA2CCTSB
SCHEMBL16449332 0.93 CYP3A4 (0.46) CYP3A4ADRB3ADRA2BADRA2CCTSB
SCHEMBL13975870 0.92 CYP3A4 (0.45) CYP3A4ADRB3ADRA2BADRA2CCTSB
SCHEMBL13975787 0.92 CYP3A4 (0.46) CYP3A4ADRB3ADRA2BADRA2CCTSB
SCHEMBL13835516 0.92 CYP3A4 (0.45) CYP3A4ADRB3ADRA2BADRA2CCTSB
SCHEMBL13835515 0.92 CYP3A4 (0.45) CYP3A4ADRB3ADRA2BADRA2CCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8951964-B2 Phenanthridine macrocyclic hepatitis C serine protease inhibitors ABBVIE INC. (US) 2015-02-10 — — US disclosed
Send feedback